<DOC>
	<DOCNO>NCT01583049</DOCNO>
	<brief_summary>Primary objective : This descriptive study primary objective determine incidence injection site systemic adverse event Triaxis administration 5th dose tetanus , diphtheria acellular pertussis vaccine 4-6 year old child</brief_summary>
	<brief_title>Post Authorisation Safety Study Triaxis 5th Dose 4-6 Year Old Spanish Children</brief_title>
	<detailed_description />
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<criteria>Aged 4 6 year day enrolment . Have receive , day enrolment , immunisation Triaxis 5th dose diphtheria , tetanus , pertussis vaccination routine practice accordance Spanish version EU SmPC Spanish immunisation recommendation . Have receive complete course immunisation diphtheria , tetanus pertussis ( 4 dos ) . Participant participantÂ´s parent/legal representative able comply study procedure . Written inform consent obtain least one parent/legal representative participant participant enrol study Have previously vaccinate 5th dose tetanus , diphtheria pertussis . Presence contraindication caution vaccination accordance Spanish version EU SmPC : 1 . Hypersensitivity vaccine diphtheria , tetanus pertussis , component vaccine residual component manufacturing process formaldehyde glutaraldehyde may present trace amount . 2 . Encephalopathy unknown origin within 7 day prior immunisation vaccine pertussis . 3 . Progressive neurological disorder , uncontrolled epilepsy , progressive encephalopathy treatment establish condition stable . 4 . Acute severe febrile illness acute infection .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>